We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
-15.48%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$504M
AUM Growth
-$158M
Cap. Flow
-$56.6M
Cap. Flow %
-11.24%
Top 10 Hldgs %
27.49%
Holding
102
New
6
Increased
45
Reduced
33
Closed
10

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$10M
2
ALKS icon
Alkermes
ALKS
+$9.75M
3
ENDP
Endo International plc
ENDP
+$6.8M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.86M
5
GILD icon
Gilead Sciences
GILD
+$5.05M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$11.5M
2
MDT icon
Medtronic
MDT
+$8.44M
3
HNT
HEALTH NET INC
HNT
+$8.35M
4
ABMD
Abiomed Inc
ABMD
+$8.02M
5
CVS icon
CVS Health
CVS
+$7.29M

Sector Composition

Rank Sector Weight
1 Healthcare 93.13%
2 Financials 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXLT
101
DELISTED
BAXALTA INC COM STK (DE)
BXLT
– –
-88,000
Closed -$3.44M
HNT
102
DELISTED
HEALTH NET INC
HNT
– –
-122,000
Closed -$8.35M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Rhenman & Partners Asset Management held 102 positions worth $504M, down 24% from $661M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $56.6M in Q1 2016, closing 10 positions and reducing 33 holdings. Its most notable exit was HEALTH NET INC, an estimated $8.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 93% a quarter earlier, followed by Financials.

Against the trend, Rhenman & Partners Asset Management opened a new position in Biogen worth $9.89M.

  • Rhenman & Partners Asset Management's largest Q1 2016 buy was Biogen: 38,000 shares worth $9.89M.
  • Rhenman & Partners Asset Management added most to Alkermes in Q1 2016, an estimated $9.75M increase.
  • Rhenman & Partners Asset Management's biggest Q1 2016 reduction was Perrigo, cutting an estimated $11.5M.
  • Rhenman & Partners Asset Management fully exited HEALTH NET INC in Q1 2016, selling an estimated $8.35M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 27% of its $504M portfolio in Q1 2016.
  • Rhenman & Partners Asset Management opened 6 new positions and closed 10 in Q1 2016.
  • Rhenman & Partners Asset Management's portfolio value fell 24% quarter-over-quarter to $504M.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2016, filed 19 Apr 2016.